FDA
-
-
-
-
-
-
-
Connect Biopharma Holdings Ltd (CNTB) PT Lowered to $6 at Canaccord
-
-
-
-
-
-
-
Connect Biopharma Reports First Quarter 2026 Financial Results and Provides Business Update
-
-
-
-
-
-
-
Connect Biopharma reports positive phase 1 data for asthma, COPD drug
-
-
-
-
-
-
-
Connect Biopharma reports new mechanism data for rademikibart drug
-
-
-
-
-
-
-
Connect Biopharma Completes Termination of its American Depositary Receipt Program and Directly Lists its Ordinary Shares on Nasdaq
-
-
-
-
-
-
-
Connect Biopharma Announces Plans to Terminate its American Depositary Receipt Program and Directly List its Ordinary Shares on Nasdaq
-
-
-
-
-
-
-
Connect Biopharma Presents Data Supporting Development of Rademikibart at the American Thoracic Society (ATS) 2025 International Conference
-
334,857 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


